Advertisement
Organisation › Details
Blackstone Life Sciences
Start | 2018-10-04 renamed | |
Group | Blackstone (Group) | |
Predecessor | Clarus Ventures LLC | |
Industry | venture capital | |
Industry 2 | LIFE SCIENCES | |
Person | Galakatos, Nicholas (Clarus Ventures 200906 Managing Director + co-founder) | |
Person 2 | Steinmetz, Michael (Clarus Ventures 2005– Managing Director before MPM Asset General Partner before Roche) | |
Region | Cambridge, MA | |
Country | United States (USA) | |
City | n. a. Cambridge, MA | |
Address record changed: 2018-12-19 | ||
Basic data | Employees | n. a. |
Record changed: 2022-03-23 |
Advertisement
More documents for Blackstone (Group)
- [1] Sanofi S.A.. (3/15/22). "Press Release: Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma". Paris....
- [2] Blackstone. (6/22/21). "Press Release: Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company". Cambridge, MA....
- [3] Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA....
- [4] Blackstone. (10/4/18). "Press Release: Blackstone Announces Agreement to Acquire Clarus, a Leading Life Sciences Investment Firm". New York, NY....
- [5] Annexon Biosciences. (3/9/17). "Press Release: Annexon Biosciences Appoints Bill Young as Chairman and Adds Tom Wiggans to Board of Directors". South San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top